Related Experiment Video
Updated: May 4, 2026
05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
2.0K
Linaclotide.
Dennis J Cada1, Terri L Levien2, Danial E Baker3
1Executive Editor, The Formulary.
Hospital Pharmacy
|January 15, 2014
Summary
The Formulary Monograph Service provides monthly drug monographs and utilization evaluations for Pharmacy & Therapeutics Committees. This service aids in informed drug selection and management for healthcare facilities.
Area of Science:
- Pharmacy and Therapeutics
- Drug Information Services
- Clinical Pharmacy
Background:
- Pharmacy & Therapeutics Committees require timely, accurate drug information.
- New drug approvals and late-stage trials necessitate ongoing evaluation.
- Effective medication use evaluations (MUE) are crucial for patient safety and formulary management.
Purpose of the Study:
- To provide comprehensive drug monographs for newly released and late-phase drugs.
- To offer summary monographs for pharmacy and nursing in-services.
- To deliver drug utilization evaluations (DUE/MUE) for targeted agents.
Main Methods:
- Distribution of 5-6 detailed monographs monthly to subscribers.
- Provision of 1-page summary monographs for quick reference.
- Inclusion of a comprehensive drug utilization evaluation/medication use evaluation (DUE/MUE) each month.
Main Results:
- Subscribers receive print and online access to monographs.
- Customization options are available to meet facility-specific needs.
- Access to "The Formulary Information Exchange" (The F.I.X.) pharmacy bulletin board is included.
Conclusions:
- The Formulary Monograph Service supports informed formulary decisions.
- The service enhances drug management through detailed evaluations and accessible information.
- Monthly drug class reviews and access to The F.I.X. further support clinical and hospital pharmacy practices.
Related Concept Videos
01:21Drugs for Treatment of Constipation-Predominant IBS
1.4K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
01:20Drugs Affecting GI Tract Motility: Other Laxatives
1.6K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.6K
01:22Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
907
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
907
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705